Retatrutide is a novel drug that belongs to the category of glucagon-like peptide-1 (GLP-1) receptor agonists. This emerging treatment has gained significant interest in the medical community for its potential to https://mathedgde148283.blognody.com/42096528/retatrutide-a-new-dawn-in-glp-1-weight-loss